Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Psoriasis × sotrastaurin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 2 Psoriasis 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Dermatitis 1

Interventions

tofacitinib 7 Etanercept 3 deucravacitinib 2 Methotrexate 2 Adalimumab 2 sotrastaurin 1 secukinumab 1 calcipotriene 1 baricitinib 1 apremilast 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00885196 2020-12-22

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

Novartis

Phase 2 Completed

Dermatitis, Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡